Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Merit Medical Systems Inc. (MMSI)

NASDAQ: MMSI · Surgical & Medical Instruments & Apparatus · South Jordan, UT

Our rating: Neutral

Neutral reaffirmed at $86.24, moderate conviction, October 30, 2026.

Breaks if: The neutral call turns Positive if trailing-twelve-month revenue growth lifts above 14% and net margin expands to 11% or higher across two consecutive quarterly reports — evidence that operating leverage is arriving ahead of expectations. It turns Cautious if trailing revenue growth decelerates below 7% or annualized free cash flow falls below $160 million, either condition observed within the next four quarterly reports.

Key figures

Market value$5.1B
Revenue, last 12 months$1.6B
Net income, last 12 months$160M
Free cash flow, last 12 months$204M
Price to earnings31.6×
Free cash flow yield4.0%
Dividend yield0.0%
Operating margin13.5%
Return on equity9.8%
Beta to the S&P 5000.69
Volatility, annualized28.7%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$416M8.4%$0.70$53M
June 30, 2026$419M9.5%$0.65$52M
March 31, 2026$382M7.5%$0.68$25M
December 31, 2025$394M10.9%$0.64$74M
September 30, 2025$384M13.0%$0.46$53M
June 30, 2025$382M13.2%$0.54$70M
March 31, 2025$355M9.8%$0.49$20M
December 31, 2024$355M9.4%$0.46$65M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

9 ledger entries and 61 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.